Insider Transactions in Q1 2021 at International Flavors & Fragrances Inc (IFF)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.4%
|
$11,288
$136.79 P/Share
|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+2.95%
|
-
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
40
-0.28%
|
$5,440
$136.79 P/Share
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
BUY
Grant, award, or other acquisition
|
Direct |
120
+0.84%
|
-
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.34%
|
$10,064
$136.79 P/Share
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
193
+0.89%
|
-
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.4%
|
$18,088
$136.79 P/Share
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.17%
|
-
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-18.3%
|
$26,410
$139.24 P/Share
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+37.24%
|
-
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-28.82%
|
$38,503
$139.24 P/Share
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+42.42%
|
-
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-21.74%
|
$26,688
$139.24 P/Share
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+39.81%
|
-
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24
-8.66%
|
$3,264
$136.21 P/Share
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
58
+17.31%
|
-
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-8.28%
|
$3,672
$136.21 P/Share
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
81
+19.9%
|
-
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-7.66%
|
$4,760
$136.21 P/Share
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
105
+18.68%
|
-
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-40.0%
|
$19,856
$136.21 P/Share
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-32.88%
|
$16,320
$136.21 P/Share
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-32.95%
|
$23,528
$136.21 P/Share
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
525
+50.0%
|
-
|
|
Feb 10
2021
|
Michael L Ducker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,668
+50.0%
|
-
|
|
Jan 08
2021
|
Anne Chwat EVP, GC, & Corp. Sec'y |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.39%
|
$18,083
$107.99 P/Share
|
|
Jan 08
2021
|
Anne Chwat EVP, GC, & Corp. Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct |
469
+1.07%
|
-
|
|
Jan 02
2021
|
Rustom Jilla CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
996
-21.92%
|
$104,580
$105.08 P/Share
|
|
Jan 02
2021
|
Rustom Jilla CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,945
+39.32%
|
-
|